Cannabis sleep gummy ingredient causes withdrawal symptoms in laboratory mice

Researchers at the University of Connecticut reported that cannabinol, a cannabis-derived compound commonly used in sleep supplements, produced physical tolerance and withdrawal symptoms in laboratory mice after repeated exposure. ScienceDaily Mind & Brain reported that the ingredient, known as CBN, is frequently marketed as a mild, natural sleep aid. [1]

The scientists tested the compound by administering repeated doses to mice to observe its behavioral and physiological effects. The animal study revealed that subjects developed a tolerance to the substance over time, alongside clear signs of withdrawal once administration ceased. The researchers noted that these physical effects mirror risks commonly associated with tetrahydrocannabinol, or THC, which is the primary psychoactive component of cannabis. [1]

The findings highlight key limitations in current scientific knowledge regarding non-psychoactive cannabis derivatives. ScienceDaily Mind & Brain reported that while CBN is widely available in consumer products, its long-term health effects and potential for physical dependence in humans remain largely unknown. [1]